Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP665237.RAmhfe_6tqyfL0z_lTKU7GfUHeYe1rqO08moeBzJphmGM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP665237.RAmhfe_6tqyfL0z_lTKU7GfUHeYe1rqO08moeBzJphmGM130_assertion type Assertion NP665237.RAmhfe_6tqyfL0z_lTKU7GfUHeYe1rqO08moeBzJphmGM130_head.
- NP665237.RAmhfe_6tqyfL0z_lTKU7GfUHeYe1rqO08moeBzJphmGM130_assertion description "[A significant therapeutic effect of (211)At has been demonstrated in prostate cancer after PSA promoter-directed NIS gene transfer in vitro and in vivo suggesting a potential role for (211)At as an attractive alternative radioisotope for NIS-targeted radionuclide therapy, in particular in smaller tumors with limited radionuclide retention time.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665237.RAmhfe_6tqyfL0z_lTKU7GfUHeYe1rqO08moeBzJphmGM130_provenance.
- NP665237.RAmhfe_6tqyfL0z_lTKU7GfUHeYe1rqO08moeBzJphmGM130_assertion evidence source_evidence_literature NP665237.RAmhfe_6tqyfL0z_lTKU7GfUHeYe1rqO08moeBzJphmGM130_provenance.
- NP665237.RAmhfe_6tqyfL0z_lTKU7GfUHeYe1rqO08moeBzJphmGM130_assertion SIO_000772 18404268 NP665237.RAmhfe_6tqyfL0z_lTKU7GfUHeYe1rqO08moeBzJphmGM130_provenance.
- NP665237.RAmhfe_6tqyfL0z_lTKU7GfUHeYe1rqO08moeBzJphmGM130_assertion wasDerivedFrom befree-2016 NP665237.RAmhfe_6tqyfL0z_lTKU7GfUHeYe1rqO08moeBzJphmGM130_provenance.
- NP665237.RAmhfe_6tqyfL0z_lTKU7GfUHeYe1rqO08moeBzJphmGM130_assertion wasGeneratedBy ECO_0000203 NP665237.RAmhfe_6tqyfL0z_lTKU7GfUHeYe1rqO08moeBzJphmGM130_provenance.